文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

单剂抗生素预防高危插管患者早发性肺炎的影响

Influence of Single-Dose Antibiotic Prophylaxis for Early-Onset Pneumonia in High-Risk Intubated Patients.
PubMed 文献 · Neurocrit Care · 2018-01-01
一句话结论神经损伤插管≥72小时患者中,插管时单剂头孢曲松2g可降低微生物确诊早发性肺炎(7.4% vs 19.8%),但未降低临床结局获益且住院死亡率更高(45.7% vs 29.7%)。

这项回顾性队列研究在UNC医学中心神经科学ICU进行,纳入2014年4月1日至2016年10月26日期间年龄≥18岁、插管≥72小时的患者172例,比较实施早发性肺炎预防方案(插管时单剂头孢曲松2g)前后结局。预防方案使微生物确诊早发性肺炎率从19.8%降至7.4%(p=0.026),但微生物确诊或临床疑似早发性肺炎合计发生率无显著差异(32.2% vs 37.4%,p=0.523)。晚发性肺炎率(34.6% vs 26.4%,p=0.25)和毒力菌种生长率(19.8% vs 14.3%,p=0.416)无差异。插管时长、ICU住院时长、住院时长及插管后30天内ICU抗生素天数均无差异,但预防组住院死亡率更高(45.7% vs 29.7%,p=0.04)。作者认为单剂抗生素可能降低微生物确诊早发性肺炎,不增加毒力菌种或晚发性肺炎,但与ICU抗生素使用天数减少或临床结局获益无关。

要点

  • 神经损伤插管≥72小时患者中,插管时单剂头孢曲松2g使微生物确诊早发性肺炎从19.8%降至7.4%(p=0.026)。
  • 预防未降低微生物确诊或临床疑似早发性肺炎合计发生率(32.2% vs 37.4%,p=0.523)。
  • 预防组住院死亡率更高(45.7% vs 29.7%,p=0.04),但研究为回顾性设计。
  • 晚发性肺炎率(34.6% vs 26.4%,p=0.25)和毒力菌种生长率(19.8% vs 14.3%,p=0.416)无显著差异。
  • 插管时长、ICU住院时长、住院时长及插管后30天内ICU抗生素天数均无差异。

适用人群与场景

  • 年龄≥18岁、收入UNC医学中心神经科学ICU、插管≥72小时的患者。

处置流程与药物剂量

  • 早发性肺炎预防方案:插管前后单次给予头孢曲松2g。

研究设计与关键结果

  • 研究类型:回顾性队列研究,比较实施早发性肺炎预防方案前后结局;样本量172例;单中心(UNC医学中心神经科学ICU);人群为年龄≥18岁、插管≥72小时的神经损伤危重患者。
  • 干预:插管时单剂头孢曲松2g预防早发性肺炎;对照:未接受预防。
  • 主要终点:微生物确诊早发性肺炎发生率预防组7.4% vs 未预防组19.8%(p=0.026)。
  • 关键次要终点:微生物确诊或临床疑似早发性肺炎合计发生率32.2% vs 37.4%(p=0.523);晚发性肺炎率34.6% vs 26.4%(p=0.25);毒力菌种生长率19.8% vs 14.3%(p=0.416);插管时长、ICU住院时长、住院时长及插管后30天内ICU抗生素天数均无差异。
  • 不良事件:住院死亡率预防组45.7% vs 未预防组29.7%(p=0.04)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为插管后单剂抗生素可能降低神经损伤插管≥72小时患者微生物确诊早发性肺炎发生率。
  • 作者认为预防策略似乎不增加毒力菌种生长率或晚发性肺炎率。
  • 作者指出该做法与ICU抗生素使用天数减少或临床结局获益无关。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early-onset pneumonia (EOP) after endotracheal intubation is common among critically ill patients with a neurologic injury and is associated with worse clinical outcomes.

METHODS: This retrospective cohort study observed outcomes pre- and post-implementation of an EOP prophylaxis protocol which involved the administration of a single dose of ceftriaxone 2 g around the time of intubation. The study included patients ≥ 18 years who were admitted to the University of North Carolina Medical Center (UNCMC) neuroscience intensive care unit (NSICU) between April 1, 2014, and October 26, 2016, and intubated for ≥ 72 h.

RESULTS: Among the 172 patients included, use of an EOP prophylaxis protocol resulted in a significant reduction in the rate of microbiologically confirmed EOP compared to those without prophylaxis (7.4 vs 19.8%, p = 0.026). However, EOP prophylaxis did not decrease the combined incidence of microbiologically confirmed or clinically suspected EOP (32.2 vs 37.4%, p = 0.523). No difference in the rate of late-onset pneumonia (34.6 vs 26.4%, p = 0.25) or virulent organism growth (19.8 vs 14.3%, p = 0.416) was observed. No difference was observed in the duration of intubation, duration of intensive care unit (ICU) stay, duration of hospitalization, or ICU antibiotic days within 30 days of intubation. In hospital mortality was found to be higher in those who received EOP prophylaxis compared to those who did not receive prophylaxis (45.7 vs 29.7%, p = 0.04).

CONCLUSIONS: The administration of a single antibiotic dose following intubation may reduce the incidence of microbiologically confirmed EOP in patients with neurologic injury who are intubated ≥ 72 h. A prophylaxis strategy does not appear to increase the rate of virulent organism growth or the rate of late-onset pneumonia. However, this practice is not associated with a decrease in days of antibiotic use in the ICU or any clinical outcomes benefit.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Lewis TD, Dehne KA, Morbitzer K, et al. Influence of Single-Dose Antibiotic Prophylaxis for Early-Onset Pneumonia in High-Risk Intubated Patients. Neurocrit Care. 2018. PMID: 29313312. doi:10.1007/s12028-017-0490-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。